type here...

CATEGORIES

Press Release

LATEST

1...567...12Page 6 of 12

TRENDING

EDITORS CHOICE

FDA Approves Drug Combination for Treating Mesothelioma

Medika Life -
First approval in 16 years for mesothelioma, a type of cancer caused by inhaling asbestos fibers SILVER SPRING, Md., Oct. 2, 2020 /PRNewswire/ -- Today, the U.S. Food...

Impact of COVID-19 on the Respiratory Device Accessories Market

Medika Life -
This report is built to visualize quantitative market trends within Anesthesia and Respiratory Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Respiratory Devices

Claims Conference Secures $13.5 Million In Funding To Get Holocaust Survivors To Vaccine Sites

Medika Life -
A New Program, Established by The Claims Conference and Funded by The German Government, Will Ensure Holocaust Survivors Globally Have the Means to Get To COVID-19 Vaccine Sites

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Medika Life -
Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories